Related by context. All words. (Click for frequent words.) 71 ALN PCS 71 isoform selective 70 selective modulator 70 ALN TTR 69 small molecule tyrosine 69 siRNA therapeutic 69 LNP formulations 69 RNAi therapeutic targeting 69 JAK2 inhibitor 69 humanized monoclonal 68 Squalamine 68 delivered RNAi therapeutic 68 ALN TTR# 68 Fc fusion protein 68 vascular disrupting agents 68 Spiegelmer ® 68 PNP inhibitor 67 synthetic retinoid 67 humanized monoclonal antibodies 67 CYT# potent vascular disrupting 67 lipid nanoparticle 67 systemic RNAi 67 immune modulating 67 RNA antagonists 67 pharmacological chaperone 67 ALN HTT 67 HSP# inhibitor 67 M2 subunit 67 cMET 67 vinca alkaloid 67 lipid nanoparticle LNP 67 orally bioavailable 67 oral prodrug 67 proteasome inhibitor 67 adenosine A2A 67 novel peptide 67 ENMD # 66 siRNA therapeutics 66 histone deacetylase inhibitor 66 NTDDS 66 MEK inhibitor 66 glucagon receptor 66 peripherally acting 66 rxRNA 66 antisense inhibitors 66 epigenetic therapies 66 THR beta agonist 66 Protein Kinase C 66 dasatinib Sprycel 66 potently inhibit 66 thromboxane A2 66 HCV protease inhibitors 66 novel therapeutic antibodies 66 Curaxins 66 HCV polymerase 66 epothilones 66 novel RNAi therapeutics 66 vidofludimus 66 histone deacetylase HDAC 66 Preclinical studies suggest 66 chimeric monoclonal antibody 66 Factor VIIa 66 histone deacetylase HDAC inhibitors 65 Locked Nucleic Acid LNA 65 ALN VSP 65 selective inhibition 65 Anticalins R 65 stable nucleic acid 65 CEQ# 65 mTOR mammalian target 65 nalbuphine ER 65 metaglidasen 65 neuroprotective properties 65 DiLA2 65 protein tyrosine phosphatase 1B 65 therapeutic monoclonal antibody 65 acetonide FA 65 pan HDAC inhibitor 65 mda 7 65 immune modulator 65 ErbB3 HER3 65 MAGE A3 ASCI 65 RNAi therapeutic targeting PCSK9 65 PDE# inhibitors 65 systemic RNAi therapeutic 65 immunomodulation 65 cardiometabolic disorders 65 Onconase 65 rhIGF-I/rhIGFBP-3 65 Maxy G# 65 selectively inhibited 65 PDE4 inhibitor 65 VEGF inhibitors 65 SERMs 65 GKAs 65 Lixivaptan 65 epothilone 65 ATL# [002] 65 anti angiogenic agents 65 Abiraterone acetate 65 MTP inhibitor 65 prostanoid 65 Tß4 65 aurora kinase 65 FGFR 65 Pimavanserin 65 liposomal formulation 65 chemokine receptor 65 immunotoxin 65 mGluR2 NAM 65 cyclophilin inhibitors 65 Posiphen TM 65 potent inhibitors 65 gamma secretase inhibitor 65 AAG geldanamycin analog 65 selectively inhibit 64 IGF IR 64 XL# XL# 64 Aviptadil 64 gastro intestinal inflammation 64 Vidaza azacitidine 64 ASG 5ME 64 investigational humanized monoclonal antibody 64 NS#/#A protease 64 antimitotic 64 A3 adenosine receptor 64 Cancidas 64 ARIKACE ™ 64 immuno modulatory 64 Chimigen TM 64 HuLuc# 64 Tekmira SNALP technology 64 Flt3 64 Orally administered 64 engineered RAP peptides 64 beta 1a 64 receptor tyrosine kinase inhibitor 64 CCR2 64 Solazed TM 64 neuroprotectant 64 molecular imaging radiopharmaceutical 64 PKC# 64 antagomirs 64 targeted radiotherapeutic 64 TTR gene 64 fibrotic disorders 64 immunomodulators 64 ALK inhibitors 64 IAP inhibitors 64 intranasal insulin product 64 JAK inhibitor 64 highly selective inhibitor 64 Cathepsin S 64 Familial Adenomatous Polyposis FAP 64 AtuPLEX 64 Hedgehog inhibitor 64 JAK3 64 lipoglycopeptide 64 cholesteryl ester transfer 64 VitiGam 64 treating neuropathic pain 64 potent cytotoxic 64 cannabinor 64 Luteinizing Hormone Releasing Hormone 64 novel oral anticoagulant 64 SinuNase ™ 64 biologic therapeutics 64 AT1R 64 phosphate S1P 64 NS5A 64 Pyridorin 64 proliferative disorders 64 histone deacetylase inhibitors 64 predictive biomarkers 64 ONCONASE R 64 Enkephalin 64 signal transduction inhibitors 64 humanized antibody 64 Sudhir Agrawal D.Phil 64 HDL Mimetic Peptide 64 plasmid DNA pDNA 64 riociguat 64 multitargeted 64 targeting CD# 64 Anticalins ® 64 Valproic acid 64 orally administered inhibitor 64 MAXY G# 64 IMiDs R 64 antifolates 64 immune modulation 64 fibrotic disease 64 Homspera TM 64 bortezomib Velcade 64 Thiovir 64 antiproliferative effects 64 AKT inhibitor 63 γ secretase 63 Vidofludimus 63 inhibitor PPI 63 thiazolides 63 targeted antifolate 63 intranasal formulation 63 CCR5 antagonist 63 cyclin dependent kinase inhibitor 63 effector function 63 Deforolimus 63 agonists antagonists 63 #ME# 63 sodium glucose transporter 63 Smac mimetics 63 EP #R 63 Apoptone 63 preclinically 63 pathophysiological effects 63 prescribed proton pump 63 generation purine nucleoside 63 mediated inhibition 63 EVIZON TM 63 potent inducer 63 NovaBay Aganocide compounds 63 antisense compounds 63 Tyrima 63 Panzem R 63 MEK inhibitors 63 Personalized Immunotherapy 63 somatostatin analogue 63 selective agonist 63 DOS# 63 sd rxRNA 63 Presents Preclinical Data 63 Y2 receptor 63 anti CD3 63 LHRH receptor positive 63 5 HT2A serotonin 63 XL# inhibits 63 siRNAs targeting 63 p# inhibitor 63 GSK3B 63 MAXY VII 63 TKM ApoB 63 PPARγ 63 androgen receptor AR 63 HCV protease 63 selective antagonist 63 SuperAntibody 63 p# MAP kinase inhibitor 63 humanised monoclonal antibody 63 Selective Electrochemical Tumor Ablation 63 ALN HPN 63 anticancer therapeutics 63 theranostic 63 glucokinase activator 63 alkylating agent 63 MyVax ® 63 TLR8 agonist 63 Th2 cytokines 63 tumorigenicity 63 AMPAKINE compounds 63 LNPs 63 BIM #A# 63 Oracea TM 63 HQK 63 calcitonin gene related 63 VEGF inhibitor 63 lipid nanoparticles 63 tkRNAi 63 HMG CoA reductase inhibitors 63 ghrelin antagonist 63 TLR9 agonist 63 inhibiting tumor 63 SNALP technology 63 systemically administered 63 Kinoid 63 affinity ligands 63 IAP inhibitor 63 inhibit replication 63 GRNCM1 63 tubulin inhibitor 63 NEUGENE R 63 HSP# inhibitors 63 volociximab 63 RNAi therapeutic 63 c myc gene 63 triciribine phosphate monohydrate 63 Sphingomab 63 polymerase inhibitors 63 taxane resistant 63 GPR# agonists 63 Onalta ™ 63 antisense oligonucleotides 63 INS# [001] 63 neuroprotective agent 63 BCR ABL inhibitors 63 ATL# [001] 63 endothelin receptor 63 JAK#/JAK# 63 immuno inflammatory 63 selective agonists 63 OHR/AVR# 63 HCV protease inhibitor 63 Nektar proprietary 63 either acutely decompensated 63 adenoviral 63 gefitinib Iressa 63 OncoVEX 63 TGF alpha 63 systemic fungal infections 63 oral ghrelin agonist 63 HepDirect prodrug 63 AEG# 63 Capesaris 63 FK# 63 Multimeric 63 novel VDA molecule 63 EGS# 62 acadesine 62 SGLT2 inhibitors 62 OvaRex R 62 Sphingomab TM 62 anti fibrotic 62 TLK# 62 Hedgehog pathway inhibitor 62 Tumour Vascular Disrupting Agent 62 Interferon beta 62 orally dosed 62 platform HDL Mimetic 62 vascular disrupting agent 62 JAK inhibitors 62 Phase IIb clinical trials 62 isoform selective inhibitors 62 NMDA antagonist 62 virus AAV 62 RhuDex ® 62 ISTODAX 62 pharmacologic approaches 62 ddRNAi 62 2 methoxyestradiol 62 Hsp# chaperone 62 PYY #-# 62 NS5b 62 Ataluren 62 Hsp# Inhibitor 62 immunomodulatory properties 62 selective immunoproteasome inhibitor 62 NV1FGF 62 demonstrated antitumor activity 62 PRT# 62 PEGPH# 62 transthyretin TTR mediated amyloidosis 62 endocrine therapies 62 GW# [003] 62 PPARgamma 62 vinorelbine tartrate 62 Immunotherapeutic 62 enzyme inhibitor 62 eIF 4E 62 OMP #M# 62 investigational therapies 62 huC# DM4 62 thymidylate synthase TS 62 CCR9 antagonist 62 TLR9 agonists 62 interferon γ 62 optimized siRNA 62 fosbretabulin 62 novel immunomodulatory 62 apoptotic pathway 62 Altastaph 62 oral picoplatin 62 mTOR inhibitors 62 CA4P 62 selective inhibitors 62 Zemiva TM 62 monoclonal antibody therapeutics 62 FBPase 62 PEG SN# 62 IL# PE#QQR 62 inhibit KSP 62 Aliskiren 62 novel histone deacetylase 62 anti secretory 62 receptor partial agonist 62 alvespimycin 62 nucleoside analog 62 subcutaneous immunoglobulin 62 Panzem 62 VitiGam TM 62 Insegia 62 TLR8 62 Symadex 62 tiapamil 62 microtubule inhibitor 62 Monoclonal antibody 62 PI3K/mTOR 62 Hedgehog signaling pathway 62 rhITF 62 TBC# 62 ERK1 2 62 candidate deforolimus 62 Gleevec resistant 62 Zybrestat 62 HERmark assay 62 cytotoxic T lymphocyte 62 non porcine pancreatic 62 TOCOSOL 62 busulfan 62 enkephalin 62 anionic backbone 62 genomic biomarker 62 insulin sensitizers 62 IMA# 62 Liposomal 62 ALK inhibitor 62 telomerase inhibitor 62 RNA antagonist 62 CORT # 62 beta interferons 62 IMiDs ® 62 inverse agonist 62 vivo validation 62 RhuDex R 62 selective androgen receptor modulator 62 oncolytic 62 antitumor effects 62 PI3K inhibitor 62 antifibrotic 62 SinuNase TM 62 compound AEZS 62 PHX# 62 selective kinase inhibitor 62 chemokine receptors 62 Dalbavancin 62 GMX# 62 SGLT 2 62 siRNA conjugates 62 immunotherapeutic vaccine 62 DPX Survivac 62 proteasome inhibitors 62 humanized anti 62 AMPK activators 62 hormone LHRH antagonist 62 CU NP 62 5 HT2C 62 CB2 receptor 62 GPR# agonist 62 Aurora kinase 62 immune modulatory 62 ADP receptor antagonist 62 endogenous ligands 62 Hsp# chaperone system 62 peptidomimetic 62 PTHrP 62 Zenvia ™ 62 soluble tumor necrosis 62 Clusterin 62 castrate resistant prostate cancer 62 thalidomide Thalomid 62 renin inhibitors 62 nucleoside analogues 62 aerosolized KL4 surfactant 62 antimetabolites 62 denileukin diftitox 62 VEGF receptor 62 small molecule inhibitors 62 nucleotide analogs 62 BCR ABL inhibitor 62 ZFP TF 62 alpha#beta# 62 SERCA2a 62 lenalidomide dexamethasone 62 mitotic kinesins 62 mGluR4 62 Solorel TM 62 investigational monoclonal antibody 62 CD8 + cytotoxic 62 delta gamma agonist 62 HGS ETR2 62 histone deacetylases 62 ALB # 62 R roscovitine 62 pathological hallmarks 62 Prodarsan ® 62 midstage clinical 62 acetylcholinesterase AChE 62 inhalation powder 62 liposomal delivery 62 CINTREDEKIN BESUDOTOX 62 catheter occlusion 62 Maribavir 62 CD# CEA 62 BRAF inhibitors 62 Panzem R NCD 62 nucleotide analog 62 reslizumab 62 therapeutic peptide 62 Romidepsin 62 immunostimulatory effects 62 R Saizen R 62 Ampligen ® 62 Trofex TM 62 CMV vaccine 62 CCR1 62 Factor Receptor 62 next generation URAT1 62 hESC derived cardiomyocytes 62 plasma pharmacokinetics 62 CCX# 62 oral PTH 62 benzimidazole 61 antimetabolite 61 intranasal insulin 61 tyrosine kinase inhibitor 61 Interferon alpha 61 NNR Therapeutics 61 heparanase 61 chemically modified siRNA 61 Adnectin 61 novel antiviral therapeutics 61 essential thrombocythemia ET 61 neuronal nicotinic receptors NNRs 61 Initiate Clinical Trial 61 Optiquel ™ 61 prodrugs 61 antisense oligonucleotide 61 kidney urologic 61 cyclic peptide 61 SIRT1 activators 61 malignant ascites 61 polymerase inhibitor 61 imatinib Gleevec ® 61 HDL Selective Delipidation 61 K ras mutations 61 itraconazole Sporanox 61 BrachySil TM 61 Davanat 61 TÎ ² 4 61 TNF alpha antagonist 61 forodesine 61 MVA BN R 61 thrombin receptor 61 GPCR targets 61 anti amnesic 61 BrachySil ™ 61 PNT# 61 5 HT4 61 neuro inflammatory 61 Spiegelmer 61 biased ligand 61 PI3K/Akt pathway inhibitor 61 orally inhaled migraine 61 Guanilib 61 imatinib Gleevec 61 Xanafide 61 GVAX ® 61 targeted nucleotide prodrug 61 polysaccharide polymer 61 androgen receptor antagonist 61 JAK1 61 Bicifadine 61 TELINTRA 61 small molecule agonists 61 Poly ICLC 61 Potelligent Technology 61 orally bioavailable mimics 61 nanopharmaceutical 61 resolvins 61 myeloproliferative diseases 61 Zorbtive TM 61 proprietary PEGylation 61 UsiRNAs 61 receptor CXCR4 61 Presents Preclinical 61 Liprotamase 61 thetreatment 61 SynCon 61 small molecule activators 61 cathepsins 61 pafuramidine maleate 61 inhibit viral replication 61 Pim kinases 61 antiangiogenic 61 potency selectivity 61 tubulin inhibitors 61 novel immunotherapeutic 61 anti CD3 antibody 61 immunoregulatory 61 mecamylamine 61 NS5B polymerase 61 anticancer therapies 61 Hypoxia Inducible Factor 61 candidates Azedra TM 61 Inosine 61 CRTH2 61 receptor antagonists 61 antibody MAb 61 Reverset 61 tkRNAi technology 61 selective serotonin 2C receptor 61 oral salmon calcitonin 61 PF # [002] 61 TNF alpha selectively neutralizing 61 druggable target 61 coagulation disorders 61 sterile lidocaine patch 61 docetaxel Taxotere ® 61 fusion enhancers 61 proprietary DuraSite ® 61 tezampanel NGX# 61 Cyclosporin 61 glucocorticoid receptors 61 patented Bioral 61 PDE# 61 psoriasis rheumatoid arthritis 61 molecular determinants 61 histone deacetylase 61 oral JAK1 61 chemopreventive agent 61 murine model 61 Hsp# inhibition 61 renin inhibitor 61 intranasal delivery 61 ESBA# 61 CB1 antagonists 61 induces apoptosis 61 ARG# 61 reversible inhibitor 61 pharmacokinetic equivalence 61 Panzem ® 61 CobaCyte 61 Wnt signaling pathway 61 hedgehog pathway 61 ribonucleotide reductase clinically validated 61 Initiates Phase II 61 KL4 surfactant 61 novel topoisomerase 61 SARMs 61 oral beclomethasone dipropionate 61 cathepsin K inhibitor 61 SMARTICLES ® 61 vivo potency 61 Inhalation Powder 61 personalized immunotherapy 61 PI3 Kinase 61 maturation inhibitors 61 lysosomal 61 DiLA2 liposomes 61 Vascugel 61 partial agonist 61 lipid particle 61 OncoVex 61 preclinical efficacy 61 Epidermal Growth Factor Receptor 61 SCIB1 61 EGFR tyrosine kinase inhibitor 61 Modrenal 61 Mipomersen 61 triphendiol 61 erlotinib Tarceva ® 61 delipidation 61 inhibitor RG# 61 Ceflatonin 61 anticoagulant reversing agent 61 RANK ligand 61 Androxal TM 61 prostaglandin synthesis 61 uricase 61 sitaxsentan 61 Virulizin ® 61 siRNA compounds 61 mGlu2 3 61 GGF2 61 PI3 kinase inhibitors 61 rxRNA ™ compounds 61 TRAIL receptor antibodies 61 adecatumumab MT# 61 molecular biomarkers 61 histone methyltransferases HMTs 61 Trofex 61 Homspera ® 61 SYN# 61 OMP #R# 61 JAK kinases 61 Lisofylline LSF 61 therapeutic modality 61 CCR5 mAb 61 small molecule thrombopoietin 61 PDE7 inhibitors 61 E#F# 61 TLE3 61 Hsp# inhibitors 61 anti angiogenic drugs 61 microsomal triglyceride transfer 61 cancer immunotherapies 61 candidate TNFerade biologic 61 Onalta 61 angiotensin receptor 61 intracellular uptake 61 hereditary emphysema 61 HIF 1α 61 DepoVax TM 61 Aurora Kinase 61 Viprinex TM 61 incyclinide 61 liposomal amphotericin B 61 Epothilones 61 aerosolized surfactant 61 ZOLINZA 61 intracellular protein 61 LHRH antagonists 61 Anavex #-# 61 Darinaparsin 61 Angiotensin converting enzyme 61 Alfacell proprietary ribonuclease 61 Enzastaurin 61 nanomedicines 61 SCD1 61 lipid lowering therapies 61 Receptors GPCRs 61 tumor antigen 61 therapeutic monoclonal antibodies 61 immunotherapeutic approaches 61 erythropoietic 61 Cytochrome P# 61 PDE4 61 thrombopoietin 61 anti tubercular 61 JAK2 Inhibitor 61 enzyme inhibitors 61 DepoVax 61 Nexavar sorafenib 61 interleukin IL -# 61 metastatic colorectal 61 small molecule modulators 61 anti infective treatments 61 Ecallantide 61 CG# [003] 61 TRV# [001] 61 immuno therapeutic 61 cytoprotective 61 Tasimelteon 61 Muraglitazar 61 cellular immunotherapy 61 AN# novel 61 Aganocide ® 61 HCD# [002] 61 cardio metabolic diseases 61 hypoxia activated prodrug 61 sphingosine 1 61 Alnylam RNAi 61 demethylating agents 61 mu opioid receptor antagonist 61 novel emulsion formulation 61 HIF 1a 61 echinocandins 61 EGFR inhibitors 61 CTAP# Capsules 61 ASONEP 61 mGluR5 NAM 61 Kosan dependence 61 MOVIPREP R 61 cardioprotective effects 61 neovascular diseases 61 insulin sensitizer 61 PPAR gamma agonists 61 nebulized budesonide 61 vaginally administered lidocaine 61 Cytotoxic 61 Novavax VLP vaccine 61 DNA methyltransferases 61 interferon alpha IFN 61 Olaparib 61 5 HT4 receptor 61 recurrent glioblastoma multiforme 61 IMiDs 61 eTag assays 60 Synavive ™ 60 OvaRex 60 vaccine GRNVAC1 60 leukotriene pathway 60 neuroinflammation 60 Upregulation 60 mGluR5 antagonist 60 IGFBP2 60 amikacin 60 enzastaurin 60 histone deacetylase HDAC inhibitor 60 YONDELIS 60 BLyS specific 60 DCCR 60 CGRP calcitonin gene 60 Vitaxin 60 NeoLipid TM 60 DepoVax ™ 60 Granulocyte Colony Stimulating Factor 60 hormone gastrin 60 retaspimycin 60 JAK2 kinase 60 lucinactant 60 osteogenic 60 selectively inhibits 60 Fludara ® 60 cytostatic 60 HIV integrase inhibitors 60 Pathway Inhibitor 60 potent inhibition 60 immunomodulatory 60 Aflibercept 60 lumiliximab 60 molecularly targeted 60 Ixabepilone 60 melanocortin receptor 60 radezolid 60 sorafenib Nexavar 60 squalamine 60 ZFP Therapeutics 60 myelofibrosis polycythemia vera 60 Zavesca r 60 siRNA mediated 60 staphylococcal vaccine 60 AMPAKINE 60 TRIOLEX HE# 60 oncolytic virus therapies 60 HIF 1alpha 60 GRNVAC1 60 visilizumab 60 FM VP4 60 elotuzumab 60 HepDirect 60 TRO# 60 non alcoholic steatohepatitis 60 predictive toxicology 60 HIV coinfected 60 Factor 5A 60 nonviral 60 P#X# antagonist 60 CCR5 receptor antagonist 60 taxane derivative 60 hypoxia inducible factor 60 PEG irinotecan 60 investigational hepatitis C 60 potent anticancer 60 Neuropeptide Y 60 antiapoptotic 60 hematological indications 60 antiviral therapies 60 monoclonal antibody MAb 60 DepoVax ™ vaccine 60 inflammatory autoimmune diseases 60 class mGluR5 inhibitor 60 OXIGON TM 60 velafermin 60 anti infective therapeutics 60 Surfaxin LS 60 GLP 1R 60 dihydrofolate reductase DHFR 60 lung fibrosis 60 Cx# [002] 60 otelixizumab 60 HCV NS3 protease 60 p# activation 60 antiangiogenic therapy 60 M# rationally 60 p# Shc 60 pDCs 60 irreversible inhibitor 60 neuro inflammatory disorders 60 mTOR inhibition 60 AFREZZA TM 60 familial amyloidotic polyneuropathy FAP 60 Methylnaltrexone 60 CDK inhibitors 60 FUSILEV enhances 60 T#I [002] 60 Collategene 60 Safinamide 60 hyaluronidase enzyme 60 potently inhibited 60 immunologic diseases 60 secondary hyperparathyroidism 60 EGFR tyrosine kinase inhibitors 60 immunomodulatory therapy 60 diagnostic biomarker 60 cardio renal 60 non nucleoside inhibitor 60 pharmacodynamic markers 60 infectious diseases autoimmune diseases 60 Reximmune C 60 romazarit 60 induced anemia 60 peptibody 60 Factor VEGF 60 Isis antisense 60 TTR amyloidosis 60 nonhuman primate model 60 Opterone R 60 Plicera 60 inhaled liposomal ciprofloxacin 60 MCSP respectively 60 epithelial tumors 60 GelSite polymer 60 Reports Preclinical Data 60 neuroinflammatory 60 pleiotropic 60 APOPTONE 60 engineered proteases 60 XmAb ® 60 neuro protective 60 Cinquil 60 PEGylated interferon 60 AERx R 60 cilengitide 60 OMNARIS HFA 60 HyperAcute 60 reverse transcriptase inhibitors 60 PTP 1B 60 mitochondrial toxicity 60 mitogenic 60 TNFa 60 immunotherapeutics 60 gastrointestinal stromal tumors GISTs 60 pharmacodynamic PD 60 Aurora kinase inhibitor 60 Triapine 60 nicotinic 60 preclinical compounds 60 RELOVAIR ™ 60 EGF receptor 60 antisense drugs 60 immuno inflammatory diseases 60 novel anticancer 60 torsemide ER 60 URG# 60 PDX pralatrexate 60 Zalypsis 60 MKC# MT 60 Anidulafungin 60 Archexin 60 geldanamycin 60 bioactive lipids 60 KNS # 60 PDE4 inhibitors 60 GA GCB 60 Kinase Inhibitor 60 recombinant enzyme 60 neuronal nicotinic receptor NNR 60 Ramoplanin 60 neurotrophic 60 Azedra TM 60 NNRs 60 potent stimulator 60 Nanobody ® 60 5 HT1A receptor 60 alkylating 60 RECOTHROM R 60 Alexza Staccato 60 5 HT3 antagonist 60 receptor subtypes 60 NeoLipid R 60 Nanobodies ® 60 GAP #B# 60 LymphoStat B TM 60 pediatric Crohn disease 60 nicotinic acetylcholine receptor 60 urate oxidase 60 Initiates Clinical 60 XL# XL# XL# XL# 60 Leukine ® 60 Blinatumomab 60 Eligen ® Technology 60 oral transdermal 60 etanercept Enbrel 60 TransVax tm 60 Hepatitis C Virus HCV 60 kinase PI3K 60 mitogen activated ERK kinase 60 viral kinetics 60 SomatoKine 60 Kuvan sapropterin dihydrochloride 60 protein kinase inhibitors 60 Tykerb lapatinib 60 biobetter 60 adult mesenchymal stem 60 lomitapide 60 inhibit EGFR 60 prophylactic vaccines 60 A1PI 60 immunomodulatory effects 60 monoclonal antibody conjugated 60 Behcet uveitis 60 PTH analogue 60 novel L DOS# 60 selective inverse agonist 60 non nucleoside 60 Omacetaxine 60 JAK3 inhibitor 60 anaplastic lymphoma kinase ALK 60 reverse transcriptase inhibitor 60 renal fibrosis